Keystone Heart Ltd. announced that is has received the European CE Mark for its TriGUARD 3, a device designed to minimize the risk of cerebral damage by deflecting embolic debris away from cerebral circulation during transcatheter aortic valve implantation and other transcatheter heart procedures.
According to the announcement, the Tri (Read more...)